Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
12.52
-0.04 (-0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novavax Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
55
56
Next >
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...
Via
Benzinga
AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday
October 11, 2023
U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Up 20% in 1 Month, Is This Stock a Buy?
September 13, 2023
As Covid cases rise, Novavax is getting more attention again. But will the momentum last?
Via
The Motley Fool
Exposures
COVID-19
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
Vaccine revenue may have slipped but could still represent billions of dollars for these companies.
Via
The Motley Fool
Exposures
COVID-19
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in
Via
Benzinga
Exposures
COVID-19
Product Safety
3 Pharma Stocks to Dump Before the Damage Is Done
October 08, 2023
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.
Via
InvestorPlace
This Could be Novavax's Big Opportunity
October 07, 2023
Novavax has lagged behind bigger rivals in the vaccine market.
Via
The Motley Fool
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
October 06, 2023
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates.
Via
The Motley Fool
Why Novavax Stock Fell Today
October 04, 2023
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...
Via
Benzinga
Exposures
COVID-19
Product Safety
Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum
October 04, 2023
Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Is Tilray (TLRY) Stock Down 4% Today?
October 04, 2023
Tilray has released its earnings report for its fiscal first quarter of 2024 and mixed results have TLRY stock on a wild ride today!
Via
InvestorPlace
These Apple Insiders Are Selling Shares of AAPL Stock
October 04, 2023
Apple stock is on the move Wednesday after several insiders at the company, including CEO Tim Cook, sold shares of AAPL.
Via
InvestorPlace
Short Sellers Are Betting Against Novavax (NVAX) Stock
October 04, 2023
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.
Via
InvestorPlace
Exposures
COVID-19
What's Going On With Moderna Stock Wednesday?
October 04, 2023
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday.
Via
Benzinga
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
October 03, 2023
U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%.
Via
Benzinga
Topics
Government
Stocks
Exposures
Political
US Equities
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
October 03, 2023
The company can now join Pfizer and Moderna in launching an updated booster in the U.S.
Via
Investor's Business Daily
Exposures
COVID-19
Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
October 03, 2023
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Pfizer and BioNTech Stocks Zoomed Higher Today
September 29, 2023
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.
Via
The Motley Fool
Exposures
COVID-19
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
September 28, 2023
With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
September 26, 2023
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.
Via
InvestorPlace
Does This Message From Moderna Mean Bad News for Novavax?
September 21, 2023
So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market.
Via
The Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
September 19, 2023
These stocks look cheap right now -- if the companies can meet their goals.
Via
The Motley Fool
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
September 18, 2023
When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to...
Via
Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why COVID Vaccine Demand Might Not Be That Strong
September 14, 2023
COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.
Via
The Motley Fool
Exposures
COVID-19
Novavax Is a Step Behind, Again. Should You Be Worried?
September 14, 2023
The FDA still is reviewing Novavax's updated vaccine candidate.
Via
The Motley Fool
Exposures
Product Safety
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
September 12, 2023
Benzinga
Via
Benzinga
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
September 11, 2023
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
The U.S.
Via
Benzinga
Exposures
COVID-19
Product Safety
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
September 11, 2023
Novavax says it's working with the FDA to answer final requests as part of the agency's review.
Via
Investor's Business Daily
Exposures
COVID-19
Product Safety
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.